In a retrospective study of 51 patients with metastatic GI cancer, 17 of whom had GC, elevated LIF levels correlated with myositis; affected patients exhibited a median LIF concentration of 21.39 pg/mL compared to 12.72 pg/mL in those without myositis. This evidence concerns the gene LIF and myositis disease.